![]() |
市場調查報告書
商品編碼
1933375
全球真空採血管市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析、未來預測(2026-2034)Vacuum Blood Collection Tube Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受慢性病盛行率上升和醫療機構診斷檢測量增加的推動,全球真空採血管市場在2025年呈現穩定成長態勢。根據本報告,全球真空採血管市場規模預計在2025年達到42.1億美元,並從2026年的43.6億美元增長至2034年的62.3億美元,預測期內複合年增長率(CAGR)為4.56%。北美地區憑藉先進的醫療基礎設施和較高的診斷檢測普及率,在2025年佔市場主導地位,市佔率達45.28%。
真空採血管是無菌一次性耗材,旨在高效採集靜脈血液樣本並維持樣本完整性。這些採血管廣泛應用於醫院、診斷實驗室和血庫。癌症、糖尿病、心血管疾病和傳染病等慢性病的日益增多,促使患者住院率上升,從而增加了對常規血液檢測和診斷的需求。
例如,根據美國癌症協會發布的統計數據,預計到2025年,美國將新增約200萬例癌症病例,這將顯著增加診斷檢測量。
市場動態
市場驅動因素
慢性病盛行率的上升是推動市場成長的主要因素。糖尿病、癌症、腎臟病和心血管疾病等慢性病需要頻繁的診斷監測,這推動了可靠血液採集解決方案的需求。此外,傳染病的反覆爆發也進一步增加了對常規檢測的需求。
真空採血管具有許多優勢,例如更高的無菌性、更精確的採血量、更低的污染風險以及與自動化分析儀的兼容性。這些優勢促使它們在高通量診斷環境中廣泛應用。
其他顯著的驅動因素包括醫院和實驗室基礎設施的擴建、血液樣本處理規範的標準化、一次性使用帶來的耗材持續需求,以及新興國家醫療基礎設施的改善。
市場限制因子
其他診斷技術(例如即時檢測 (POCT) 和微量採樣裝置)的普及預計將抑制市場成長。這些技術所需的血液量極少,且通常採用指尖採血技術,從而減少了靜脈採血的需求。
歐洲PMC公司2020年的一項調查顯示,93%的受訪者認為POCT有助於改善病患護理,這顯示人們對其他檢測方法的接受度正在不斷提高。 此外,毛細血管採血系統和微流控裝置正變得越來越受歡迎,尤其是在慢性病監測方面。
市場機會
常規和預防性醫療保健的擴展帶來了巨大的成長機會。在政府措施、保險覆蓋範圍擴大以及企業主導的健康促進計劃的支持下,人們對早期疾病診斷的認識不斷提高,推動了對預防性血液檢測的需求。
2025年2月,印尼政府啟動了一項價值1.8354億美元的年度免費健康篩檢計劃,進一步增強了對採血耗材的需求。
市場挑戰
新興國家診斷服務取得受限仍是一項重大挑戰。臨床意識不足、醫療設施短缺、報銷政策限制以及轉診延遲等因素促使診斷延誤,尤其是在發展中地區。價格壓力、原料成本波動以及真空洩漏和溶血等品質風險也對市場成長構成挑戰。
真空採血管市場趨勢
技術創新正在改變市場格局。智慧標籤、增強型穩定劑、微型化管體設計以及改進的材料成分等創新正在提高樣本穩定性並提升實驗室效率。 2025年7月,OraSure Technologies推出了HEMAcollect PROTEIN採血管,以滿足日益增長的蛋白質體學研究應用需求。
依產品類型劃分,受血液檢測量成長的推動,EDTA採血管將在2026年佔36.96%的市場佔有率。依材料劃分,塑膠採血管預計在2025年佔85.4%的市場佔有率,憑藉其安全性和便利性優勢,繼續保持領先地位。 依應用領域劃分,其他領域(臨床化學和分子診斷)將在2024年佔47.5%的市場佔有率,這主要得益於肝腎疾病盛行率的上升。依最終用戶劃分,臨床實驗室將在2025年佔主導地位,市場佔有率達到43.5%,這主要得益於檢測量的增長和實驗室規模的擴大。
北美地區憑藉強有力的報銷政策和先進的診斷基礎設施,將繼續保持領先地位,2025年市場規模將達到19.1億美元,2026年將達到19.8億美元。歐洲地區2025年的市場規模將達到8.2億美元,而亞太地區由於醫療保健覆蓋範圍的擴大,2025年的市場規模將達到6.9億美元。 拉丁美洲和中東及非洲市場將呈現溫和成長,到 2025 年,市場規模將分別達到 4.3 億美元和 1.6 億美元。
The global vacuum blood collection tube market demonstrated steady growth in 2025, supported by the rising prevalence of chronic diseases and increasing diagnostic testing volumes across healthcare settings. According to the report, the global vacuum blood collection tube market size was valued at USD 4.21 billion in 2025 and is projected to grow from USD 4.36 billion in 2026 to USD 6.23 billion by 2034, exhibiting a CAGR of 4.56% during the forecast period. North America dominated the market with a 45.28% share in 2025, driven by advanced healthcare infrastructure and high diagnostic test adoption.
Vacuum blood collection tubes are sterile, single-use consumables designed to collect venous blood samples efficiently while maintaining sample integrity. These tubes are widely used in hospitals, diagnostic laboratories, and blood banks. The increasing burden of chronic diseases such as cancer, diabetes, cardiovascular disorders, and infectious diseases has resulted in a growing number of patient admissions, thereby increasing the demand for routine blood testing and diagnostics.
For instance, according to 2025 statistics published by the American Cancer Society, approximately 2.0 million new cancer cases are estimated to occur in the U.S., significantly contributing to diagnostic testing volumes.
Market Dynamics
Market Drivers
The growing prevalence of chronic conditions is a major driver supporting market growth. Chronic diseases such as diabetes, cancer, kidney disorders, and cardiovascular diseases require frequent diagnostic monitoring, increasing the demand for reliable blood collection solutions. Additionally, recurring outbreaks of infectious diseases further boost routine testing requirements.
Vacuum blood collection tubes offer advantages such as improved sterility, accurate blood volume collection, reduced contamination risk, and compatibility with automated analyzers. These benefits support their widespread adoption in high-throughput diagnostic environments.
Other prominent drivers include the expansion of hospital and laboratory infrastructure, standardization of blood sample handling regulations, recurring consumable demand due to single-use nature, and improving healthcare infrastructure in emerging economies.
Market Restraints
The adoption of alternative diagnostic technologies, such as point-of-care testing (POCT) and microsampling devices, is expected to restrain market growth. These technologies require minimal blood volumes and often rely on finger-prick methods, reducing the need for venous blood collection.
According to a 2020 study published by Europe PMC, 93% of respondents believed POCT could enhance patient care, highlighting the increasing acceptance of alternative testing methods. Additionally, capillary blood collection systems and microfluidic devices are gaining popularity, especially for chronic disease monitoring.
Market Opportunities
The expansion of routine and preventive healthcare presents significant growth opportunities. Increasing awareness regarding early disease diagnosis, supported by government initiatives, insurance coverage, and employer-sponsored wellness programs, is driving demand for preventive blood testing.
In February 2025, the Indonesian government launched an annual free health screening program worth USD 183.54 million, further strengthening demand for blood collection consumables.
Market Challenges
Limited diagnostic access in emerging countries remains a key challenge. Factors such as lack of clinical awareness, insufficient healthcare facilities, limited reimbursement policies, and delayed referrals contribute to late diagnosis, especially in developing regions. Pricing pressure, raw material cost volatility, and quality risks such as vacuum leaks and hemolysis also pose challenges to market growth.
Vacuum Blood Collection Tube Market Trends
Technological advancements are reshaping the market landscape. Innovations such as smart labeling, enhanced stabilizers, miniaturized tube designs, and improved material compositions are enhancing sample stability and laboratory efficiency. In July 2025, OraSure Technologies launched the HEMAcollect PROTEIN blood collection tube, targeting the growing demand from proteomic research applications.
By product type, EDTA tubes dominated the market with a 36.96% share in 2026, driven by increasing hematology testing volumes. By material, the plastic segment accounted for 85.4% share in 2025 and is projected to maintain dominance due to safety and convenience benefits. By application, the others segment (clinical chemistry and molecular diagnostics) held a 47.5% share in 2024, supported by rising liver and kidney disorder prevalence. By end user, clinical laboratories dominated with a 43.5% share in 2025, driven by increasing test volumes and lab expansion.
North America led the market with a valuation of USD 1.91 billion in 2025 and USD 1.98 billion in 2026, supported by strong reimbursement policies and advanced diagnostics infrastructure. Europe recorded USD 0.82 billion in 2025, while Asia Pacific reached USD 0.69 billion in 2025, driven by expanding healthcare access. Latin America and the Middle East & Africa witnessed moderate growth, with valuations of USD 0.43 billion and USD 0.16 billion respectively in 2025.
Competitive Landscape
Key players such as BD, Greiner Bio-One International GmbH, and Cardinal Health dominated the market due to strong product portfolios and global presence. Companies are focusing on R&D, regulatory approvals, and product launches to strengthen their market position.
Conclusion
The global vacuum blood collection tube market was valued at USD 4.21 billion in 2025 and is projected to grow from USD 4.36 billion in 2026 to USD 6.23 billion by 2034, driven by rising chronic disease prevalence, increasing diagnostic testing volumes, and technological advancements in blood collection products. North America maintained market dominance, while Europe and Asia Pacific showed strong growth potential. Despite challenges from alternative testing technologies and limited diagnostic access in emerging regions, expanding preventive healthcare initiatives, recurring consumable demand, and continuous product innovation are expected to support sustained market growth through 2034.
Segmentation By Product Type
By Material
By Application
By End User
By Region
North America (By Product Type, By Material, By Application, By End User, and by Country)
Europe (By Product Type, By Material, By Application, By End User, and by Country/Sub-region)
Asia Pacific (By Product Type, By Material, By Application, By End User, and by Country/Sub-region)
Latin America (By Product Type, By Material, By Application, By End User, and by Country/Sub-region)
Middle East & Africa (By Product Type, By Material, By Application, By End User, and by Country/Sub-region)
Rest of the Middle East & Africa (By Material)